Zdrowie i gospodarka · 20/11/2001
FDA Reopens Comment Period for Prescription Drug Labeling Guidance
The FDA is extending the comment period for its draft guidance on prescription drug labeling until November 26, 2001, in response to industry requests and to allow more time for public input.
Source: Federal Register — Food and Drug AdministrationOpen original release →